10x Genomics (TXG) EBITDA Margin Growth (5y) (2023 - 2026)
Powered by 
Analysis
10x Genomics (TXG) EBITDA Margin Growth (5y) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 226.93 Bn | 222.99 Bn | 8.34 Bn |
| 2 | Danaher | 145.94 Bn | 141.60 Bn | 3.61 Bn |
| 3 | Agilent Technologies | 42.55 Bn | 40.79 Bn | 1.04 Bn |
| 4 | Illumina | 32.95 Bn | 31.78 Bn | 770.00 Mn |
| 5 | Revvity | 14.53 Bn | 13.51 Bn | 416.87 Mn |
| 6 | Bio-Techne | 11.31 Bn | 11.04 Bn | 211.39 Mn |
| 7 | Bio-Rad Laboratories | 10.34 Bn | 8.72 Bn | 345.80 Mn |
| 8 | Repligen | 9.46 Bn | 8.44 Bn | 110.04 Mn |
| 9 | Bruker | 8.91 Bn | 8.73 Bn | 416.00 Mn |
| 10 | 10x Genomics | 8.16 Bn | 7.61 Bn | 112.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -403.00 |
| Mar 31, 2026 | -165.00 |
| Dec 31, 2025 | 35,322.00 |
| Sep 30, 2025 | 6,922.00 |
| Jun 30, 2025 | 10,930.00 |
| Mar 31, 2025 | 226.00 |
| Dec 31, 2024 | -1,947.00 |
| Sep 30, 2024 | -1,249.00 |
| Jun 30, 2024 | -870.00 |
| Mar 31, 2024 | -3,795.00 |
| Dec 31, 2023 | 11,829.00 |
| Sep 30, 2023 | -2,091.00 |